Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Share News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,770.00
Bid: 1,770.00
Ask: 1,774.00
Change: -10.00 (-0.56%)
Spread: 4.00 (0.226%)
Open: 1,772.00
High: 1,776.00
Low: 1,746.00
Prev. Close: 1,780.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: ODDO BHF Cuts IAG To Neutral From Buy

Thu, 30th Apr 2020 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

ODDO BHF CUTS INTERNATIONAL CONSOLIDATED AIRLINES GROUP TO 'NEUTRAL' (BUY) - PRICE TARGET 2.80 (3.50) EUR

----------

LIBERUM CUTS RIGHTMOVE PRICE TARGET TO 470 (570) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS BT GROUP PRICE TARGET TO 110 (146) PENCE - 'SELL'

----------

DEUTSCHE BANK RAISES COMPASS GROUP PRICE TARGET TO 1506 (1200) PENCE - 'HOLD'

----------

HSBC CUTS SEGRO PRICE TARGET TO 833 (890) PENCE - 'HOLD'

----------

HSBC CUTS LAND SECURITIES PRICE TARGET TO 679 (897) PENCE - 'HOLD'

----------

JPMORGAN CUTS LAND SECURITIES PRICE TARGET TO 685 (775) PENCE - 'NEUTRAL'

----------

HSBC CUTS BRITISH LAND CO TO 'HOLD' ('BUY') - TARGET 385 (643) PENCE

----------

JPMORGAN CUTS BRITISH LAND CO PRICE TARGET TO 460 (490) PENCE - 'NEUTRAL'

----------

HSBC RAISES ASTRAZENECA PRICE TARGET TO 6690 (6450) PENCE - 'REDUCE'

----------

CREDIT SUISSE RAISES ASTRAZENECA PRICE TARGET TO 9000 (8500) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1550 (1450) PENCE - 'UNDERWEIGHT'

----------

GOLDMAN CUTS STANDARD CHARTERED PRICE TARGET TO 820 (850) PENCE - 'BUY'

----------

JPMORGAN CUTS RIO TINTO PRICE TARGET TO 4730 (4870) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES POLYMETAL PRICE TARGET TO 1800 (1500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES GLENCORE PRICE TARGET TO 170 (140) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS FRESNILLO PRICE TARGET TO 550 (600) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES BHP PRICE TARGET TO 1830 (1820) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ANTOFAGASTA PRICE TARGET TO 700 (660) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES ANGLO AMERICAN PRICE TARGET TO 2500 (2300) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE CUTS INTERTEK PRICE TARGET TO 4400 (4550) PENCE - 'NEUTRAL'

----------

SHORE CAPITAL RESUMES J SAINSBURY WITH 'HOLD'

----------

SOCGEN CUTS NEXT TO 'SELL' ('HOLD') - TARGET 3522 (3998) PENCE

----------

JEFFERIES CUTS NEXT PRICE TARGET TO 5600 (6700) PENCE - 'HOLD'

----------

JPMORGAN RAISES WPP PRICE TARGET TO 750 (630) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

JPMORGAN RAISES MITCHELLS & BUTLERS TO 'OVERWEIGHT' ('NEUTRAL') TARGET 340(490)P

----------

JPMORGAN CUTS MARSTONS PRICE TARGET TO 57 (128) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS JD WETHERSPOON PRICE TARGET TO 600 (1100) PENCE - 'UNDERWEIGHT'

----------

CITIGROUP CUTS TUI PRICE TARGET TO 125 (260) PENCE - 'SELL'

----------

PEEL HUNT CUTS GENUS TO 'HOLD' ('BUY')

----------

DEUTSCHE BANK RAISES IMI PRICE TARGET TO 1000 (940) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES SYNTHOMER PRICE TARGET TO 300 (265) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES SYNTHOMER PRICE TARGET TO 317 (274) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES ELEMENTIS PRICE TARGET TO 100 (75) PENCE - 'BUY'

----------

BERENBERG RAISES PLUS500 PRICE TARGET TO 1120 (1033) PENCE - 'HOLD'

----------

BARCLAYS CUTS WEIR GROUP PRICE TARGET TO 1200 (1750) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 400 (550) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES HOCHSCHILD MINING PRICE TARGET TO 170 (160) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS FERREXPO PRICE TARGET TO 130 (190) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS WORKSPACE PRICE TARGET TO 930 (980) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS GREAT PORTLAND PRICE TARGET TO 660 (825) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS DERWENT LONDON PRICE TARGET TO 2850 (3720) PENCE - 'UNDERWEIGHT'

----------

JEFFERIES RAISES IP GROUP TO 'BUY' ('HOLD') - TARGET 73 (72) PENCE

----------

INVESTEC RAISES KINGFISHER TO 'HOLD' ('SELL') - TARGET 160 (170) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

CITIGROUP RAISES RESTAURANT GROUP TO 'BUY' ('NEUTRAL')

----------

RBC CUTS HURRICANE ENERGY PRICE TARGET TO 30 (65) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS YOUNG & COS BREWERY PRICE TARGET TO 1230 (1550) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS PETRA DIAMONDS PRICE TARGET TO 5 (6) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS GEM DIAMONDS PRICE TARGET TO 40 (50) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS HELICAL PRICE TARGET TO 435 (475) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS DRAPER ESPRIT PRICE TARGET TO 487 (727) PENCE - 'BUY'

----------

JEFFERIES CUTS ALLIED MINDS PRICE TARGET TO 56 (99) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
12 Aug 2016 07:06

Genus suffers legal setback Stateside

(ShareCast News) - Genus suffered a legal setback Stateside as a US judge handed down a series of verdicts against the animal genetics specialist. The US District Court for Wisconsin ruled that two of Genus rival ST´s patents were valid and had been infringed and that ABS, a unit of Genus, had mater

Read more
11 Aug 2016 10:01

Genus and Sexing still battling over semen

(ShareCast News) - Animal genetics company Genus announced the first jury verdicts in its antitrust litigation against Inguran, operating as Sexing Technologies, relating to ABS's 'Genus Sexed Semen' processing technology. The FTSE 250 firm said that at the trial in the US District Court for the Wes

Read more
11 Aug 2016 07:45

Genus Says US Court Finds Against Inguran But Sees No Injury To Genus

Read more
4 Aug 2016 11:59

Thursday broker round-up

(ShareCast News) - Next: Goldman Sachs reiterates sell with a target price of 4800p. Standard Chartered: JP Morgan maintains overweight with a 800p target. Shire: JP Morgan reiterates overweight with a 6300p target. Genus: HSBC stays at buy with a 2200p target. Nichols: UBS keeps at buy with a ta

Read more
4 Jul 2016 08:37

BROKER RATINGS SUMMARY: Liberum Downgrades Property Stocks

Read more
4 Jul 2016 08:21

CORRECT (01/07): WINNERS & LOSERS SUMMARY

Read more
1 Jul 2016 15:58

LONDON MARKET CLOSE: Stocks Close Week After Brexit Vote On A High

Read more
1 Jul 2016 11:09

LONDON MARKET MIDDAY: Carney Boosts Stocks As easyJet Eyes Own Brexit

Read more
1 Jul 2016 09:11

WINNERS & LOSERS SUMMARY: Dignity And Genus Benefit From Upgrades

Read more
1 Jul 2016 08:51

BROKER RATINGS SUMMARY: Berenberg - Buy Dignity; Liberum - Buy Genus

Read more
1 Jul 2016 07:24

LONDON BRIEFING: Carney Lifts Brexit Blues With Policy Assurance

Read more
20 Jun 2016 09:25

ITV, Wolseley are Liberum's top-picks in case of Bremain, Brexit

(ShareCast News) - Depending on whether the UK finally decided to 'Remain' or 'Leave' then different London-listed securities were likelier to 'outperform' their respective sectors, Liberum said. The broker's 'top-picks' under a 'Remain', 'Leave' and 'Either way' scenario were, ITV, Wolseley and Bal

Read more
26 May 2016 14:30

FTSE 250 movers: Ibstock retreats as Pets at Home accelerates

(ShareCast News) - The FTSE 250 slipped further into the red late as Thursday wore on, despite having peeped its head above water around midday. Leading the index lower, shares in Ibstock subsided as the brick maker reported a slow start to the year for its UK clay business had lasted four months b

Read more
18 May 2016 09:49

Genus announces collaboration with Caribou Biosciences

(ShareCast News) - Genus announced a strategic collaboration with US-based Caribou Biosciences that will give the London-listed animal genetics group exclusive license to Caribou's gene editing technology platform. Caribou's CRISPR-Cas9 technology accurately targets and cuts DNA to produce precise a

Read more
18 May 2016 07:01

Genus Signs Gene Editing Platform Deal With Caribou Biosciences

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.